XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.3
Investment in RP Finance, LLC (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Oct. 31, 2023
Jul. 31, 2023
Feb. 03, 2020
Investment in RP Finance, LLC [Line Items]      
Percentage of issued and outstanding shares 12.00%    
Income from interest $ 0 $ 0  
Debt instrument amount $ 9,375 $ 9,375  
Ownership interests 37.50% 37.50%  
Line of Credit Agreement [Member]      
Investment in RP Finance, LLC [Line Items]      
Amount of revolving commitment to funds     $ 50,000,000
Description line of credit facility The Company owns 37.5% of the equity interests in RP Finance and is required to fund 37.5% of funding requests from Cornerstone Pharmaceuticals under the RPF Line of Credit. The Instrument owns 37.5% of the equity interests in RP Finance, and is required to fund 37.5% of funding requests from Cornerstone Pharmaceuticals under the RPF Line of Credit. The remaining 25% equity interests in RP Finance are owned by other stockholders of Cornerstone Pharmaceuticals.